ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1674635
This article is part of the Research TopicGenomic and Transcriptomic Insights into ESKAPE Pathogens' Antimicrobial ResistanceView all articles
Genetic and Virulence Factors Behind the Success of High-Risk Pseudomonas aeruginosa Clones: Insights from Comparative Genomics and an Experimental Infection Model
Provisionally accepted- 1Albert Einstein Research and Education Institute, Hospital Israelita Albert Einstein, SAO PAULO, Brazil
- 2Hospital Israelita Albert Einstein, São Paulo, Brazil
- 3Universidade Estadual de Campinas, Campinas, Brazil
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Pseudomonas aeruginosa causes severe healthcare-associated infections. High-risk clones are defined by global dissemination and multidrug resistance, yet virulence is heterogeneous. We sought to map accessory-genome determinants associated with high-risk clones by integrating whole-genome sequencing (WGS) with a Caenorhabditis elegans infection model. Methods: We analyzed 84 clinical isolates plus publicly available genomes using WGS, phylogenomics, and resistome/virulome profiling. Virulence was measured by C. elegans slow-killing (SK). A GWAS of accessory-genome sub elements (AGEs) identified loci with high- (HVA) or low-virulence association (LVA). Coding sequences were annotated with Prokka and InterPro. Results: Although HR and sporadic clones carried a similar total number of antimicrobial-resistance genes, 15/67 (22.38%) genes/variants were enriched in high-risk clones, producing class-level enrichment (p < 0.002) for aminoglycosides, phenicols, trimethoprim, sulfonamides, and tetracyclines, but not β-lactams or fosfomycin. Many determinants are recognized mobile-element cargo such as integron cassettes or plasmid/ICE-borne genes (e.g., aadA, dfrB, blaVIM-2, crpP, cmlA, floR), indicating a mobility-linked resistome in high-risk clones. GWAS identified 113 AGEs linked to SK virulence (42 HVA, 71 LVA). HVA regions were enriched for pyoverdine (fpvA, pvdE, pvdD) and LPS O-antigen (wbpA/B/D) loci, whereas LVA regions were enriched for ICE/conjugation/integrase motifs. cdsA and clpP were newly associated with P. aeruginosa virulence. Phenotypically, high-risk clones were more often strong biofilm producers and none were non-producers. High-risk clones were not consistently more virulent in SK, suggesting success reflects persistence traits (mobile DNA and biofilm under antibiotic pressure). Conclusions: Accessory-genome GWAS revealed two risk dimensions: acute-virulence programs (HVA) versus mobility functions (LVA) favoring persistence and spread. Because SK measures acute virulence, readouts did not align with high-risk designations. Genomic reports should combine HR assignment with accessory-genome and effector profiling to support earlier containment and mechanism-aware, biofilm-focused care.
Keywords: Pseudomonas aeruginosa, High-risk clones, antimicrobial resistance, Virulence Factors, Comparative genomics, Caenorhabditis elegans, genome-wide association study (GWAS)
Received: 28 Jul 2025; Accepted: 13 Oct 2025.
Copyright: © 2025 Sales, Leaden, Martins, Koga, Toniolo, Gatti De Menezes, Mori, Martino and Severino. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Patricia Severino, patricia.severino@einstein.br
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.